期刊文献+

Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma:a cross-sectional case-control study from Chinese patients with HBV infection 被引量:8

Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma:a cross-sectional case-control study from Chinese patients with HBV infection
在线阅读 下载PDF
导出
摘要 BACKGROUND: Diabetes mellitus (DM) is regarded as a new risk factor for hepatocellular carcinoma (HCC), but few studies have focused on the potential role of DM in the progression of cirrhosis to HCC as well as in patients with simple HBV infection. METHODS: A cohort of 1028 patients, treated at our hospital and with a hospital discharge diagnosis of HCC and/or cirrhosis, was screened. Among them, 558 were diagnosed with chronic HBV infection and 370 were analyzed statistically according to the diagnostic, inclusion and exclusion criteria. The demographic, clinical, metabolic, virological, biochemical, radiological and pathological features were analyzed and the multivariate logistic regression model was used to determine the potential role of DM. RESULTS: In 248 cirrhotic patients, 76 were diabetic and their mean duration of DM was 4.6 years. In 122 HCC patients with cirrhosis, 25 were diabetic and their mean duration of DM was 4.4 years. Univariate analysis showed that compared with cirrhotic patients, the HCC patients had a higher percentage in males (P=0.001), a lower percentage in DM patients (P=0.039), a higher percentage in cigarette smokers (P=0.005), a higher percentage in patients with AFP】400 ng/mL (P【0.001), higher values of white blood cells (P【0.001), hemoglobin (P【0.001) and platelet (P【0.001), increased levels of ALT (P【0.001) and GGT (P【0.001), higher total bilirubin (P=0.018) and albumin levels (P【0.001), and a lower international normalized ratio (P【0.001). Multivariate logistic regression analysis showed that DM was anindependent associated factor for HCC [odds ratio (OR)=0.376; 95% CI, 0.175-0.807; P=0.012]. Even after the HCC patients were restricted to those with decompensated cirrhosis and compared with decompensated cirrhotic patients, the similar result was observed (OR=0.192; 95% CI, 0.054-0.679; P=0.010). CONCLUSIONS: DM is an independent factor in the progression of cirrhosis to HCC, but the role may be contrary to our current viewpoint. To clarify the causal relationship of DM and HCC, prospective and experimental studies are required. BACKGROUND: Diabetes mellitus (DM) is regarded as a new risk factor for hepatocellular carcinoma (HCC), but few studies have focused on the potential role of DM in the progression of cirrhosis to HCC as well as in patients with simple HBV infection. METHODS: A cohort of 1028 patients, treated at our hospital and with a hospital discharge diagnosis of HCC and/or cirrhosis, was screened. Among them, 558 were diagnosed with chronic HBV infection and 370 were analyzed statistically according to the diagnostic, inclusion and exclusion criteria. The demographic, clinical, metabolic, virological, biochemical, radiological and pathological features were analyzed and the multivariate logistic regression model was used to determine the potential role of DM. RESULTS: In 248 cirrhotic patients, 76 were diabetic and their mean duration of DM was 4.6 years. In 122 HCC patients with cirrhosis, 25 were diabetic and their mean duration of DM was 4.4 years. Univariate analysis showed that compared with cirrhotic patients, the HCC patients had a higher percentage in males (P=0.001), a lower percentage in DM patients (P=0.039), a higher percentage in cigarette smokers (P=0.005), a higher percentage in patients with AFP>400 ng/mL (P<0.001), higher values of white blood cells (P<0.001), hemoglobin (P<0.001) and platelet (P<0.001), increased levels of ALT (P<0.001) and GGT (P<0.001), higher total bilirubin (P=0.018) and albumin levels (P<0.001), and a lower international normalized ratio (P<0.001). Multivariate logistic regression analysis showed that DM was anindependent associated factor for HCC [odds ratio (OR)=0.376; 95% CI, 0.175-0.807; P=0.012]. Even after the HCC patients were restricted to those with decompensated cirrhosis and compared with decompensated cirrhotic patients, the similar result was observed (OR=0.192; 95% CI, 0.054-0.679; P=0.010). CONCLUSIONS: DM is an independent factor in the progression of cirrhosis to HCC, but the role may be contrary to our current viewpoint. To clarify the causal relationship of DM and HCC, prospective and experimental studies are required.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2013年第4期385-393,共9页 国际肝胆胰疾病杂志(英文版)
基金 supported by grants from the National Natural Science Foundation of China(No.30772859) the Research Fund of the China-Japan Friendship Hospital,Ministry of Health(No.2010-QN-01)
关键词 diabetes mellitus hepatocellular carcinoma CIRRHOSIS chronic hepatitis B diabetes mellitus hepatocellular carcinoma cirrhosis chronic hepatitis B
  • 相关文献

参考文献14

  • 1Donghui Li,Sai–Ching J. Yeung,Manal M. Hassan,Marina Konopleva,James L. Abbruzzese.Antidiabetic Therapies Affect Risk of Pancreatic Cancer[J]. Gastroenterology . 2009 (2)
  • 2Giovanni Tarantino,Paolo Conca,Fabrizio Pasanisi,Manuela Ariello,Maria Mastrolia,Adriano Arena,Marianna Tarantino,Francesco Scopacasa,Raffaela Vecchione.Could inflammatory markers help diagnose nonalcoholic steatohepatitis?[J]. European Journal of Gastroenterology & Hepatology . 2009 (5)
  • 3Giovan Giuseppe Di Costanzo,Massimo De Luca,Giovanni Tritto,Filippo Lampasi,Luigi Addario,Alfonso Galeota Lanza,Maria Teresa Tartaglione,Francesco Paolo Picciotto,Antonio Ascione.Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis[J]. European Journal of Gastroenterology & Hepatology . 2008 (7)
  • 4Detlef Schuppan,Nezam H Afdhal.Liver cirrhosis[J]. The Lancet . 2008 (9615)
  • 5Lei Yu,Dana A. Sloane,Chuanfa Guo,Charles D. Howell.Risk Factors for Primary Hepatocellular Carcinoma in Black and White Americans in 2000[J]. Clinical Gastroenterology and Hepatology . 2006 (3)
  • 6Hashem B. El-serag,Thomas Tran,James E. Everhart.Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma[J]. Gastroenterology . 2004 (2)
  • 7Takumi Kawaguchi,Takafumi Yoshida,Masaru Harada,Takao Hisamoto,Yumiko Nagao,Tatsuya Ide,Eitaro Taniguchi,Hiroto Kumemura,Shinichiro Hanada,Michiko Maeyama,Shinji Baba,Hironori Koga,Ryukichi Kumashiro,Takato Ueno,Hisanobu Ogata,Akihiko Yoshimura,Michio Sata.Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3[J]. The American Journal of Pathology . 2004 (5)
  • 8Yu–Xiao Yang,Sean Hennessy,James D. Lewis.Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients[J]. Gastroenterology . 2004 (4)
  • 9Teh-Ia Huo,Wing-Yu Lui,Yi-Hsiang Huang,Gar-Yang Chau,Jaw-Ching Wu,Pui-Ching Lee,Full-Young Chang,Shou-Dong Lee.Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study[J]. The American Journal of Gastroenterology . 2003 (10)
  • 10Ronnie Tung-Ping Poon,Sheung-Tat Fan,John Wong.Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma?[J]. The American Journal of Gastroenterology . 2002 (6)

共引文献7

同被引文献91

引证文献8

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部